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1. Introduction 
Acute-onset postoperative endophthalmitis is characterized by marked inflammation of 
intraocular fluids and tissues. Despite appropriate therapeutic intervention, endophthalmitis 
may result in severe visual loss. Postoperative endophthalmitis has been reported following 
every type of ocular surgery but because cataract surgery is the most commonly performed 
type of ocular surgery, this setting is the most frequent cause in clinical practice.  
2. Incidence 
The incidence of acute-onset postoperative endophthalmitis (Table 1) after cataract 
surgery has steadily declined from 2% in the first half of the twentieth century to current 
levels ranging from 0.03% to 0.21% (Leopold, 1971; Allen & Mangiaracine, 1964; Aaberg et 
al., 1998; West et al., 2005; Jensen et al., 2008; Moshirfar et al., 2007; Freeman et al., 2010; 
Ravindran et al., 2009; Wykoff et al., 2010). The reported rate of delayed-onset (chronic) 
postoperative endophthalmitis following cataract surgery in one single-center series was 
0.017% (Mezaine et al., 2009). 
 
 Author Years No. of cases Incidence % 
1 Leopold (1920-1940) Meta-analysis 2.00 
2 
Allen & 
Mangiaracine 
(1958-1962) 22/20,000 0.09 
3 Aaberg et al. (1984-1994) 34/41,654 0.07 
4 West et al. (1994-2001) 1026/4,77,627 0.21 
5 Jensen et al. (1997-2007) 40/29,276 0.14 
6 Moshirfar et al. (2003-2005) 14/20,013 0.07 
7 Freeman et al. (1996-2005) 754/4,90,690 0.15 
8 Ravindran et al. (2007-2008) 38/42,426 0.09 
9 Wykoff et al. (1995-2009) 8/28,568 0.03 
Table 1. Reported incidence of acute-onset postoperative endophthalmitis 
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3. Risk factors 
There are concerns that clear corneal sutureless temporal incision cataract surgery may 
increase the risk of endophthalmitis (Nichamin et al., 2006). In a nosocomial survey (2002-
2009) at a university teaching hospital involving resident, fellow, and faculty surgeons, 
there was no increase in the incidence of endophthalmitis  in the era of sutureless clear 
corneal cataract surgery (Wykoff et al., 2010).   Other more established risk factors for 
developing acute-postoperative endophthalmitis  include patients with diabetes mellitus, 
cases with posterior capsular rupture and advanced age (Hatch et al., 2009; Doft et al., 
2001). A range of risk factors for acute-onset postoperative endophthalmitis is 
summarized in Table 2. 
 
A. Preoperative:  
1. Diabetes mellitus. 
2. Immune compromise. 
3. Chronic blepharitis. 
4. Infection of the lacrimal drainage system. 
5. Contaminated eye drops. 
6. Contact lens wear. 
7. Contralateral ocular prosthesis. 
B. Intraoperative: 
1. Application of 2% Xylocaine gel before povidone-iodine instillation. 
2. Prolonged surgery. 
3. Secondary IOL. 
4. Posterior capsular rupture. 
5. Vitreous loss. 
6. Contaminated irrigating solution. 
7. Clear corneal incision (controversial). 
C. Post operative 
1. Wound leak. 
2. Vitreous incarceration. 
Table 2. Risk Factors for Acute-onset Postoperative Endophthalmitis 
4. Classification, isolates and clinical features 
The diagnosis of endophthalmitis is made by the constellation of clinical symptoms and 
signs. The symptoms and signs vary according to time of presentation (acute–onset 
postoperative endophthalmitis (APE) (occurring within six weeks of cataract surgery) and 
chronic postoperative (CPE) endophthalmitis (presenting 6 weeks or more after the surgery) 
(Johnson et al., 1997). 
APE is associated with rapid onset of visual loss, pain, marked intraocular inflammation 
usually with hypopyon (Figure 2) and caused by rapidly growing bacteria with 
coagulase-negative Staphylococci (Figure 2) being the most common isolated organism 
(followed by other Gram positive organisms like Staphylococcus aureus, Streptococcus 
species and Gram negative bacteria) (Han et al., 1996).  Endophthalmitis caused by the 
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coagulase-negative staphylococci may have less severe inflammatory signs, often 
creating difficulty in distinguishing between an infectious and a noninfectious etiology 
on clinical grounds. 
APE, when caused by more virulent organisms such as other Streptococcus species and 
Gram negative  organisms, may be associated with corneal infiltrate, cataract wound 
abnormalities, afferent pupillary defect, loss of red reflex, initial light perception-only 
vision, and symptom onset within 2 days of surgery. (Johnson et al., 1997).    In CPE 
caused by less virulent bacteria and fungi, the inflammation is often low-grade and slowly 
progressive (Table 3). Propionibacterium acnes is the most common organism isolated in 
CPE (Mezaine et al., 2009;  Clark et al., 1999). Other less virulent organisms include Gram 
positive organisms (coagulase negative Staphyloccocus, Corynebacterium species) (Fox et al., 
1991), Gram negative organisms (Alcaligenes xylosoxidans, Acinetobacter calcoaceticus, 
Ochrobactrum anthropi) (Aaberg et al., 1997; Gopal et al., 2000) and fungi (Candida species, 
Aspergillus species, and Curvularia species) (Pflugfelder et al., 1988; Pathengay et al., 
2006a). Mild to moderate vitritis, white posterior capsular plaque (Figure 3) and keratic 
precipitates are common clinical signs in CPE (Mezaine et al., 2009; Johnson et al., 1997). 
Hypopyon is less frequently seen as compared to acute-onset postoperative 
endophthalmitis (Johnson et al., 1997).  The presence of a white plaque inside the capsular 
bag has been reported in a large series of patients with P. acnes endophthalmitis 
(Nichamin et al., 2006). However, this plaque is not unique to P. acnes and has been 
described in CPE caused by other microorganisms as well (Mezaine et al., 2009; Pathengay 
et al., 2006a). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Acute-onset postoperative endophthalmitis. 
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Fig. 2. Coagluase negative Staphylococci isolates from vitreous growing on blood agar.  
 
 
Fig. 3. Delayed-onset postoperative endophthalmitis. 
 
Bacteria  Fungi 
P. acnes Candida parapsilosis 
S. epidermidis Other Candida species 
Corynebacterium species Paecilomyces species 
Xanthomonas maltophilia Aspergillus species 
Alcaligenes xylosoxidans Acremonium species 
Table 3. Bacteria and Fungi commonly associated with delayed postoperative 
endophthalmitis. 
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5. Differential diagnosis 
The differential diagnosis of endophthalmitis following cataract surgery is summarized in 
Table 4. Toxic anterior segment syndrome (TASS) can mimic infectious endophthalmitis 
and is often associated with various toxins entering the eye at the time of surgery (Doshi et 
al., 2010; Cutler Peck et al., 2010). 
The inflammatory response is usually seen with in the first 24 hours after surgery and there 
is little or no pain. In TASS, corneal edema can be severe and extending “wall to wall”. It can 
be associated with a hypopyon and fibrin formation in the anterior chamber and the 
vitreous is typically not involved, as is the case with an infectious endophthalmitis. 
Dehemoglobinized red blood cells in the vitreous cavity can also be confused with 
endophthalmitis (Nguyen et al., 2006). Retained lens fragments have been reported to cause 
a marked inflammatory reaction with hypopyon, which may also clinically resemble 
infectious endophthalmitis (Irvine et al., 1992). 
 
A. Toxic anterior segment syndrome (TASS).  
B. Retained lens material. 
C. Flare-up of pre-existing uveitis. 
D. Dehemoglobinized vitreous hemorrhage. 
Table 4. Differential Diagnosis of Endophthalmitis after Cataract Surgery. 
6. Management 
It is important to examine the surgical wound for leakage and vitreous incarceration which 
may need to be addressed at the time of treatment. If visualization of the posterior segment 
is limited by either inflammatory material or corneal edema, B-scan echography may help 
assess the degree of vitreous opacification and determine the presence of either choroidal or 
retinal detachment.  
The treatment of endophthalmitis is usually performed using topical, peribulbar, or 
retrobulbar anesthesia. A vitreous tap is more commonly utilized but pars plana 
vitrectomy (PPV) is considered in more advanced cases. The goals of PPV include the 
following: 
1. Obtain intraocular fluid for microbiological analysis (the vitreous specimen generally 
yields higher culture positivity rates compared to aqueous) (Han et al., 1996); 
2. Debulk vitreous of toxins, microorganisms and inflammatory debris. 
Although postoperative endophthalmitis is a clinical diagnosis, confirmation by culture of 
intraocular fluid specimens is an important step in the management. Vitreous can be 
obtained using a needle (vitreous tap) or by PPV. If a vitreous tap is employed, the use of a 
23-gauge butterfly needle (Figure 4) may offer better stability than a straight needle attached 
directly to a syringe (Raju & Das, 2004). The undiluted vitreous specimen is then inoculated 
onto the culture media. The Endophthalmitis Vitrectomy Study reported no significant 
differences between 3-port PPV versus needle tap/biopsy with respect to microbiologic 
yield, operative complications, short-term (9-12 months) retinal detachment risk, or visual 
outcomes (Han et al., 1999). 
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Fig. 4. Butterfly needle used for vitreous tap (upper right: injection of intravitreal antibiotics 
in separate syringes). 
PPV may be performed using small-gauge sutureless (Tan et al., 2008) (Figure 5) or 20-
gauge vitrectomy techniques and instrumentation. In the Endophthalmitis Vitrectomy 
Study (EVS), a goal of PPV was the removal of approximately 50% of the formed vitreous. 
If the cornea is clear and the pupil dilates well, a more complete PPV can be considered. 
In typical APE, it is not generally necessary to remove the IOL. In some patients, visibility 
may be improved by stripping fibrin from the iris or the surface of IOL (Friberg, 1991). In 
selected cases of delayed postoperative endophthalmitis caused by Propionobacterium acnes 
or fungi which are not responsive to initial treatment, or when there is recurrence of 
inflammation, IOL explantation may be considered along with the removal of entire 
capsular bag (Clark et al., 1999). 
 
 
 
Fig. 5. 23-gauge PPV performed in a patient with acute-onset postoperative 
endophthalmitis. 
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Intravitreal antibiotic therapy (Figure 6) is standard treatment of presumed bacterial 
postoperative endophthalmitis (Table 5). When endophthalmitis is initially suspected, the 
pathogen is not known therefore the choice of antimicrobial agent must be made empirically. 
The EVS reported that the combination of vancomycin (1 mg/0.1 cc) and amikacin (0.4 mg/ 
0.1 cc) were usually effective against the broad spectrum of bacteria causing APE 
(Endophthalmitis Vitrectomy Study Group, 1995). In the EVS, 100% of the Gram positive 
bacteria were susceptible to vancomycin, 89% of the Gram negative bacteria were 
susceptible to both amikacin and ceftazidime, and the remaining 11% were resistant to both 
amikacin and ceftazidime (Han et al., 1996). However, there are multiple reports of toxicity 
following administration of intravitreal aminoglycosides, including macular infarction 
(Campochiaro & Lim, 1994). An alternative to the aminoglycosides for coverage of Gram 
negative organisms is the use of intravitreal ceftazidime 2.25 mg, a third-generation 
cephalosporin (Jay et al., 1987; Roth & Flynn, 1997). Although ceftazidime may precipitate 
when mixed with vancomycin, this has not been reported to alter its effectiveness in the 
clinical setting (Kwok et al., 2002).  It is generally recommended to use a separate needle and 
syringe for each antibiotic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Intravitreal antibiotics administered at the end of PPV. 
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A. Seidel test for potential wound leak 
B. Use topical, peribulbar or retrobulbar anesthesia for either vitreous tap or vitrectomy 
C. Obtain intraocular specimen 
1. 30-gauge needle for anterior chamber tap (optional) 
2. 25 or 23-gauge needle for vitreous tap 
3. Pars plana vitrectomy (PPV) 
D. Preparation of intravitreal antibiotics (usually by pharmacist) 
E. Dosages for intravitreal injection 
1. Vancomycin 1 mg  
2. Ceftazidime 2.25 mg or amikacin 0.4 mg  
3. Dexamethasone 0.4 mg (Optional) 
Table 5. Suggested Endophthalmitis Treatment In The Setting Of A Clear Corneal Incision 
Intravitreal corticosteroids reduce inflammation-induced ocular damage associated with 
presumed bacterial endophthalmitis. In a prospective randomized clinical trial of 63 bacterial 
endophthalmitis  cases, intravitreal dexamethasone was reported to reduce inflammation 
scores early in the course of  treatment but had no independent influence on the final visual 
outcome (Das et al., 1999). In a series of endophthalmitis caused by virulent bacteria such as 
Gram negative organisms and Staphylococcus aureus, better visual acuity outcomes were 
reported after adjunctive treatment with intravitreal dexamethasone (Irvine et al., 1992). 
Intravitreal triamcinolone acetonide has also been reported to reduce inflammation without 
exacerbating the infection in a small series of endophthalmitis cases (Pathengay et al., 2006b). 
Postoperative fungal endophthalmitis more commonly presents as a delayed-onset (chronic) 
case. Fungi should be suspected in patients that fail to respond to standard intravitreal 
antibiotic therapy. Traditionally, intravitreal amphotericin B was used commonly to treat 
suspected fungal endophthalmitis, but intravitreal voriconazole (with or without adjunctive 
oral therapy) is becoming more frequently employed (Vasconcelos-Santos & Nehemy, 2009). 
7. Endophthalmitis vitrectomy study 
The EVS was a large multicenter randomized clinical trial comparing vitreous tap to PPV in 
patients presenting with endophthalmitis within 6 weeks of cataract surgery or secondary 
IOL implantation (Table 6). A total of 420 patients with APE after cataract surgery was 
randomly assigned to undergo 3-port PPV or tap/biopsy. They were also randomized to 
receive either systemic antibiotics (ceftazidime and amikacin) or no systemic antibiotics. At 
the end of 9 months, patients were assessed for final visual acuity and media clarity.  
7.1 Primary results 
In patients who presented with hand motions (HM) visual acuity or better, there were no 
statistically significant differences between eyes assigned to vitreous tap versus PPV. In 
patients who presented with light perception (LP) visual acuity, PPV was associated with 
significantly more favorable outcomes. The usage of systemic antibiotics was not associated 
with significant improvements in either visual acuity or media clarity outcomes.  
(Doft & Barza, 1996; Barza et al., 1997) 
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A. Background - largest series of endophthalmitis after cataract surgery (N=420) 
1. EVS enrolled endophthalmitis patients after extracapsular cataract extraction, scleral 
tunnel phacoemulsification, or secondary IOL within 6 weeks of surgery. 
2. Initial results were reported in 1995 and subsequent reports were published in the  
following years. 
B. EVS primary results 
1. Patients with LP vision fared better with initial PPV. 
2. When patients presented with HM or better vision, equal visual acuity outcomes were 
reported in the PPV and vitreous tap groups. 
3. There was no apparent benefit from the use of systemic antibiotics (amikacin and 
ceftazidime) compared to controls (no IV antibiotics). 
C. EVS secondary results 
1. Gram positive bacteria were isolated from 94.2% patients and Gram negative bacteria in 
6.5%. Coagulase-negative micrococci were the most common bacteria isolated in 70% of 
patients. Diabetes mellitus was associated with a higher yield of Gram positive, 
coagulase-negative micrococci.  
2. Patients with diabetes mellitus and visual acuity better than LP achieved better visual 
outcomes with initial PPV (not statistically significant). 
3. Additional procedures (as a result of worsening intraocular inflammation or infection 
or for complications) after the initial treatment: 8% of PPV eyes and 13% of tap eyes. 
4. There was no statistical difference between PPV and tap groups in terms of 
microbiological yield, operative complications, retinal detachment (8.3%) or visual 
acuity outcomes (overall, 53% equal to or better than 20/40 in EVS). 
5. In the EVS the incidence of retinal detachment (RD) was 8.3% and there was no 
difference in frequency of RD based on whether initial management was PPV or tap.  
Table 6. Summary of the Endophthalmitis Vitrectomy Study (EVS) 
7.2 Other results 
Confirmed microbiologic growth was demonstrated in 69.3% of EVS patients. Undiluted 
vitreous produced a higher percentage of confirmed positive cultures when compared with 
aqueous (Barza et al., 1997). Gram positive bacteria were isolated from 94.2% patients and 
Gram negative bacteria from 6.5%. Coagulase-negative micrococci were the most common 
bacteria isolated in 70% of patients. An additional procedure (as a result of worsening 
intraocular inflammation or infection or for complications) after the initial treatment was 
performed in 8% of PPV eyes and 13% of tap eyes. (Doft et al., 1998). In the EVS the 
incidence of retinal detachment (RD) was 8.3% and there was no difference in frequency of 
RD based on whether initial management was PPV or tap. (Doft et al., 2000). 
Although patients in the EVS derived no demonstrable benefit from these systemic antibiotics, 
the study made no recommendations regarding treatment with other systemic antibiotics (eg, 
systemic fluoroquinolones) or systemic antimicrobial agents for other types of endophthalmitis 
(eg, chronic, bleb-associated, traumatic, fungal, and endogenous forms) (Flynn & Scott, 2008). 
Endophthalmitis patients with significant opacification of the anterior chamber precluding 
the use of PPV, or without light perception visual acuity, were excluded from the EVS. 
Because these eyes with more severe infection or involving more virulent organisms were 
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excluded from the EVS, the effect might have shifted the EVS outcomes to more favorable 
results. Although the EVS provides general guidelines, the clinician ultimately must decide 
on the best treatment strategy for the individual patient (Flynn & Scott, 2008). 
The EVS, conducted during 1991-1994, enrolled patients with scleral tunnel incisions. A 
follow-up retrospective study of patients recruited during 1996-2005 with clear corneal 
incisions reported generally similar outcomes compared with the EVS (Lalwani et al., 2008). 
8. The European Society of Cataract and Refractive Surgeons (ESCRS) 
Endophthalmitis Study 
The European Society of Cataract and Refractive Surgeons (ESCRS) Endophthalmitis Study 
was conducted at 24 centers in 9 European countries from 2003 to 2006. It was a partially 
masked, randomized, placebo-controlled study evaluating the prophylactic effect of 
intracameral cefuroxime injection and/or perioperative levofloxacin eye drops on the 
incidence of endophthalmitis after cataract surgery. A total of 16,603 patients was recruited 
in the four arms of the study. 
The ESCRS Study reported that the use of intracameral cefuroxime was associated with a 
significant reduction in the incidence of postoperative endophthalmitis compared to 
instillation of topical antibiotics. The rate of endophthalmitis was 4.92 times higher in the 
control group than the cefuroxime-treated group. Perioperative topical levofloxacin was 
associated with a reduced incidence of endophthalmitis but this difference did not achieve 
statistical significance. In this study, reported risk factors included clear corneal incisions, 
silicone  IOLs, and surgical complications (Barry et al., 2006; Endophthalmitis Study Group, 
European Society of Cataract & Refractive Surgeons, 2007) 
9. Prophylaxis 
The presumed source of the causative organism in the EVS and ESCRS Study was the ocular 
surface of study patients (Bannerman et al., 1997; Seal et al., 2008). In a systematic review of 
all prophylactic methods for cataract surgery, instillation of 5% povidone–iodine on the 
conjunctiva 3 minutes before the surgery received the highest rating and was the only 
measure that gained a Grade B rating based on evidence from randomized clinical trials 
(Ciulla et al., 2002).  
 
 
Fig. 7. Povidone-iodine used as prophylaxis preoperatively. 
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Povidone-iodine (Figure 7) has reported efficacy in reducing the bacterial load in the 
conjunctival fornices and is more effective than silver protein solution (Speaker & Menikoff, 
1991). A recent study reported that repeated irrigation of the operative field with povidone-
iodine 0.25% achieved an extremely low bacterial contamination rate in the anterior 
chamber at the completion of cataract surgery (Shimada et al., 2011). 
Preoperative antibiotic administration is associated with a significant decrease in 
conjunctival bacterial colony counts after the use of certain antibiotics but has not shown 
superiority to antisepsis with povidone–iodine (Isenberg et al., 1985). A  prospective study 
demonstrated that the addition of moxifloxacin drops had no significant effect in the 
preoperative reduction of conjunctival bacterial colonization above the effect of povidone–
iodine 5% alone (Halachimi-Eyal et al., 2009). 
Antibiotics in the irrigating fluid for cataract surgery have been reported to reduce anterior 
chamber bacterial contamination rates significantly but their effect on endophthalmitis 
prevention is less convincing (Sobaci et al., 2003; Srinivasan et al., 2008).  The reported lack 
of effectiveness of both vancomycin and gentamicin  in the irrigation fluid may be due to the 
requirement of more than 140 minutes to exhibit bactericidal effect, whereas the half-life of 
antibiotics in the anterior chamber is only 51 minutes (Gritz et al., 1996).  Intracameral 
antibiotics have many negative consequences including potential  toxicity, increased cost, 
and the potential for more rapid emergence of resistant bacteria. At least 10 patients in the 
EVS developed endophthalmitis in spite of receiving antibiotics in the irrigating fluid for 
cataract surgery. 
Other antibiotics which have been used intracamerally include vancomycin, cefazolin and 
moxifloxacin. Although the safety of moxifloxacin has been reported, there are no published 
reports about its usage in routine clinical cases (Arbisser, 2008).                         
Intracameral vancomycin has been reported to significantly reduce the incidence of 
postoperative endophthalmitis after cataract surgery in a large series from the UK 
(Anijeet  et al., 2010). Since vancomycin is generally reserved for the treating severe life-
threatening or organ-threatening infections, such as endophthalmitis, the United States 
Centers for Disease Control and Prevention guidelines recommended that this drug 
should not be used for prophylaxis. Similarly, a study from Spain has reported 
prophylactic efficacy of intracameral cefazolin, in diminishing the rate of postoperative 
endophthalmitis without toxic effects on the cornea or retina (Romero et al., 2006). 
Concerns about the intracameral antibiotic include lack of commercial availability, 
problems with dosing, pH, and improper constituents within the injection that could 
lead to postoperative TASS, possible fungal or bacterial contamination during mixing or 
cystoid macular edema. 
Traditionally, subconjunctival antibiotics were commonly administered after intraocular 
surgery but are less often utilized today. The rationale for subconjunctival antibiotic 
administration at the completion of the procedure is to inhibit growth of bacteria that may 
gain entry into the eye. Studies performed evaluating the effectiveness of prophylactic 
subconjunctival antibiotics in reducing the incidence of postoperative endophthalmitis 
reported conflicting results (Iyer et al., 2004). 
The use of povidone–iodine to reduce the intraoperative bacterial load and the creation of 
reliably self-sealing incisions to reduce ingress of contaminants are probably the most 
important of all these factors in reducing the risk of acute postoperative bacterial 
endophthalmitis. Table 7 summarizes techniques in the reduction of the risk of 
endophthalmitis after cataract surgery. 
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A. Proposed Methods 
1. Preoperative povidone-iodine antisepsis 
2. Preoperative topical antibiotics 
3. Properly sized and constructed incision 
4. Antibiotics in irrigating solution 
5. Antibiotics injected into AC 
6. Postoperative subconjunctival antibiotics 
7. Postoperative topical antibiotics 
B.  Current Choices for Intracameral Antibiotics 
1. Vancomycin 
2. Cefuroxime 
3. Moxifloxacin 
C. Potential Complications of Intracameral Antibiotics 
1. Microbial contamination during mixing 
2. Incorrect preparation and dosage 
3. Allergy 
4. Cystoid macular edema 
5. Corneal edema 
Table 7. Prophylaxis For Endophthalmitis After Cataract Surgery. 
10. Conclusion 
The incidence of endophthalmitis after cataract surgery is variable from about 0.03%-0.15%. 
Povidone-iodine prophylaxis is generally recommended for cataract surgery. Blepharitis, 
vitreous loss and wound leak are major potential preoperative, intraoperative and 
postoperative risk factors for endophthalmitis. The significance of clear corneal incisions as 
a potential risk factor for endophthalmitis remains controversial. The differential diagnosis 
of endophthalmitis include TASS, retained lens fragments, uveitis and chronic vitreous 
hemorrhage. The most common organisms causing post-operative endophthalmitis are 
coagulase negative staphylococci. In the treatment of presumed bacterial endophthalmitis, 
intravitreal vancomycin and ceftazidime are commonly used for empiric coverage of both 
Gram positive and Gram negative bacteria. In about 50% of patients, 20/40 or better visual 
acuity can be achieved after treatment. 
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